V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003755 | 210009251 | null | null | null | 2016-03-13 | 2016-04-01 | null | null | null | FEC + DOCETAXEL | 100206801 |
| 210003760 | 210009254 | null | null | null | null | 2019-02-01 | Capecitabine | null | null | CAPECITABINE | 100447681 |
| 210003761 | 210009255 | 1.69 | 58.8 | Palliative (P) | 2020-04-18 | 2020-05-02 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100595718 |
| 210003762 | 210009256 | null | 53.8 | Adjuvant (A) | 2017-11-08 | 2018-02-27 | FEC 60 or 75 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101823616 |
| 210003763 | 210009257 | null | null | null | null | 2018-11-04 | PERTUZUMAB + TRASTUZUMAB | null | null | PERTUZUMAB + TRASTUZUMAB | 101207248 |
| 210003764 | 210009258 | 1.63 | 71.2 | Neo-adjuvant (N) | 2019-04-03 | 2019-07-27 | FEC 100 | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101029123 |
| 210003765 | 210009259 | 1.58 | 76.5 | Curative (C) | null | 2017-05-11 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 2 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101794773 |
| 210003766 | 210009260 | 1.75 | 91.6 | Neo-adjuvant (N) | 2019-10-29 | 2019-10-29 | null | N | N | CAPECITABINE | 100041288 |
| 210003770 | 210009263 | 1.53 | 103.4 | Palliative (P) | 2018-11-16 | 2018-12-20 | Neratinib | null | N | NERATINIB | 101804234 |
| 210003772 | 210009264 | null | null | Curative (C) | null | 2017-09-14 | Capecitabine | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101069244 |
| 210003777 | 210009268 | 1.65 | 0 | Adjuvant (A) | 2018-11-06 | 2019-01-23 | null | 02 | N | LETROZOLE + PALBOCICLIB | 101028848 |
| 210003779 | 210009270 | 0 | 71.65 | Palliative (P) | null | 2017-11-18 | Capecitabine | N | N | CAPECITABINE | 101717009 |
| 210003781 | 210009271 | null | null | null | null | 2022-05-05 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100179815 |
| 210003786 | 210009275 | 1.56 | 0 | null | 2019-10-11 | 2019-10-11 | VINORELBINE | 02 | null | VINORELBINE | 101741961 |
| 210003791 | 210009278 | 1.63 | 53 | Neo-adjuvant (N) | 2020-09-17 | 2020-09-24 | null | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100632682 |
| 210003793 | 210009280 | 1.68 | 59.2 | null | 2018-09-16 | 2018-11-25 | null | 02 | null | ABEMACICLIB + FULVESTRANT | 101588817 |
| 210003796 | 210009282 | null | null | null | 2019-08-16 | 2019-08-28 | Capecitabine | 02 | null | CAPECITABINE | 100395150 |
| 210003798 | 210009284 | 1.64 | 104 | Adjuvant (A) | 2020-08-23 | 2020-11-24 | PERTUZUMAB + TRASTUZUMAB | N | N | PERTUZUMAB + TRASTUZUMAB | 100334595 |
| 210003802 | 210009286 | 1.57 | 65.65 | Adjuvant (A) | null | 2018-06-11 | null | null | N | CARBOPLATIN + GEMCITABINE | 101468225 |
| 210003805 | 210009288 | 1.5 | 43.4 | Curative (C) | null | 2019-11-24 | null | null | N | PALBOCICLIB | 100072693 |
| 210003806 | 210009289 | 1.71 | 69.65 | Palliative (P) | 2017-12-21 | 2018-01-12 | Carboplatin + Docetaxel | null | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 101532763 |
| 210003808 | 210009291 | 1.66 | 94.8 | null | 2018-12-08 | 2018-12-08 | null | 02 | null | FULVESTRANT + PALBOCICLIB | 100749803 |
| 210003811 | 210009293 | 1.58 | 80.6 | Palliative (P) | 2016-07-31 | 2016-08-17 | ATEZOLIZUMAB + NAB PACLITAXEL | 01 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100844377 |
| 210003812 | 210009294 | 1.53 | 64.9 | Neo-adjuvant (N) | 2017-10-03 | 2017-10-11 | GEMCARBO | null | N | CARBOPLATIN + GEMCITABINE | 100552101 |
| 210003815 | 210009297 | 1.63 | 83.2 | null | 2020-08-08 | 2020-09-12 | null | 02 | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100858927 |
| 210003818 | 210009298 | 1.62 | 69 | null | 2020-03-05 | 2020-05-08 | ATEZOLIZUMAB + NAB PACLITAXEL | N | null | CYCLO + DOCETAXEL + TRASTUZUMAB | 101420244 |
| 210003821 | 210009301 | null | 61.7 | null | 2019-04-09 | 2019-04-09 | null | 02 | null | CAPECITABINE | 101309940 |
| 210003822 | 210009302 | 1.64 | null | Palliative (P) | 2017-08-13 | 2017-08-21 | null | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100568439 |
| 210003824 | 210009303 | 1.6 | 60.5 | Palliative (P) | 2018-07-24 | 2018-09-18 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100036411 |
| 210003826 | 210009305 | 1.72 | 65.3 | Neo-adjuvant (N) | 2020-01-07 | 2020-01-08 | null | null | N | ATEZOLIZUMAB | 101339951 |
| 210003828 | 210009306 | 1.73 | 74.4 | null | null | 2019-03-31 | CARBOPLATIN + PACLITAXEL | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 101679686 |
| 210003830 | 210009308 | 1.72 | 76.7 | null | null | 2018-08-11 | EC | N | null | EC | 101383942 |
| 210003832 | 210009309 | 1.54 | 0 | null | 2018-11-10 | 2019-01-25 | Capecitabine | Y | null | CAPECITABINE | 100586130 |
| 210003834 | 210009310 | null | null | null | 2016-10-27 | 2016-11-10 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100149178 |
| 210003835 | 210009311 | null | null | null | 2016-02-22 | 2016-05-13 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101442024 |
| 210003836 | 210009312 | null | 75.5 | Adjuvant (A) | 2020-01-24 | 2020-02-06 | CARBOPLATIN + GEMCITABINE | null | N | CARBOPLATIN + GEMCITABINE | 100323428 |
| 210003838 | 210009314 | 1.76 | 49.7 | Adjuvant (A) | null | 2021-09-06 | Epirubicin (weekly) | null | null | PALBOCICLIB | 101607323 |
| 210003839 | 210009315 | 1.42 | 97.4 | null | 2021-01-23 | 2021-01-29 | Capecitabine | 02 | null | CAPECITABINE | 101616051 |
| 210003840 | 210009316 | 1.72 | 59.7 | null | 2018-07-12 | 2018-12-08 | Capecitabine | N | null | EC | 101100324 |
| 210003844 | 210009317 | 1.75 | 54.05 | null | null | 2020-09-30 | Carboplatin + Docetaxel | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100348651 |
| 210003846 | 210009319 | 1.61 | 49 | Adjuvant (A) | 2016-02-29 | 2016-04-06 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101408426 |
| 210003848 | 210009321 | 1.57 | 70.2 | Adjuvant (A) | 2018-07-29 | 2018-08-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100349970 |
| 210003849 | 210009322 | 1.69 | 68.4 | null | 2018-12-19 | 2018-12-27 | null | 02 | null | PACLITAXEL + TRASTUZUMAB | 100363280 |
| 210003850 | 210009323 | 1.59 | 92.8 | null | 2019-08-14 | 2019-08-17 | null | 02 | null | NAB-PACLITAXEL | 100865385 |
| 210003851 | 210009324 | 1.69 | 90.2 | null | 2020-02-08 | 2020-02-16 | Letrozole + Palbociclib | null | null | EVEROLIMUS | 101793615 |
| 210003854 | 210009326 | 1.76 | 64.5 | Neo-adjuvant (N) | null | 2021-07-02 | Eribulin | 02 | N | ERIBULIN | 100202734 |
| 210003855 | 210009327 | 1.44 | 80 | Neo-adjuvant (N) | 2021-02-10 | 2021-03-11 | CARBO + DOCETAXEL + TRASTUZUMAB | 02 | N | EPIRUBICIN | 101448000 |
| 210003859 | 210009330 | 1.67 | 61.15 | null | 2019-02-21 | 2019-02-21 | Letrozole + Palbociclib | N | null | LETROZOLE + PALBOCICLIB | 100934002 |
| 210003862 | 210009331 | 1.6 | 86.7 | Palliative (P) | 2019-11-17 | 2019-11-23 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | PACLITAXEL + TRASTUZUMAB | 100376955 |
| 210003863 | 210009332 | 1.63 | 55.75 | Palliative (P) | 2017-04-16 | 2017-06-18 | CARBOPLATIN + GEMCITABINE | null | N | CARBOPLATIN + GEMCITABINE | 100867305 |